Back to Treatments
Second Opinion

Rare Disease Diagnosis

罕见病诊断

Duration

5-14 days

Recovery

No recovery needed

$

Savings

~64% vs US

Price Comparison
China$500 - $2,000
$1,250
United States$2,000 - $5,000
$3,500
Save approximately 64%

Average savings compared to US prices

About This Treatment

Specialized diagnostic evaluation for undiagnosed or rare conditions at China's designated rare disease centers. China has established a national network of 324 hospitals with rare disease expertise and a national rare disease registry. Combines advanced genetic testing, metabolic screening, and expert consultation from multidisciplinary rare disease teams.

Procedure Steps
1

Comprehensive History Review

Detailed review of medical history, family pedigree analysis, and compilation of all previous diagnostic workup.

Duration: 1-2 days
2

Advanced Diagnostic Testing

Targeted genetic panels, whole exome sequencing, metabolic screening, and specialized biomarker analysis.

Duration: 5-10 days
3

Multidisciplinary Evaluation

Rare disease team including geneticists, metabolic specialists, and organ-specific experts collaboratively evaluate findings.

Duration: 1-2 days
4

Diagnosis and Management Plan

Final diagnostic determination with treatment options, clinical trial eligibility, and long-term management recommendations.

Duration: 1-2 days
Benefits
  • Access to China's national rare disease center network with specialized expertise
  • Advanced genetic sequencing at significantly lower cost
  • Large patient populations provide unique diagnostic experience
  • Connection to ongoing clinical trials for rare conditions
Considerations
  • Diagnosis may remain uncertain despite extensive testing
  • Some rare disease treatments may not be available locally
  • Extended stay required for comprehensive workup
  • Genetic findings may have implications for family members

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.